Resistance patterns of nosocomial urinary tract infections in urology departments: 8-year results of the global prevalence of infections in urology study

World Journal of Urology

Volumn 32, Issue 3, 2014, Pages 791-801

  Tandogdu, Zafer ^a   Cek, Mete ^b   Wagenlehner, Florian ^c   Naber, Kurt ^d   Tenke, Peter ^e   van Ostrum, Edgar ^f   Bjerklund Johansen, Truls ^g  

^a Taksim Teaching Hospital   (Turkey)

^b TRAKYA UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^c UNIVERSITY HOSPITAL GIESSEN   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e Urology Department   (Hungary)

^f Italy   (Netherlands)

^g AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Antibiotic resistance; Global; Nosocomial urinary tract infections

Indexed keywords

ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC RESISTANCE; BACTERIA; BACTERIAL INFECTIONS; CLINICAL TRIAL; CONTROLLED STUDY; CROSS INFECTION; EPIDEMIOLOGY; EUROPE; FEMALE; FOLLOW UP; HUMAN; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; MULTICENTER STUDY; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; URINARY TRACT INFECTIONS;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; EUROPE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; URINARY TRACT INFECTIONS;

EID: 84901496259     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-013-1154-8     Document Type: Article

References (17)

1. Gastmeier P, Kampf G, Wischnewski N, Hauer T, Schulgen G, Schumacher M et al (1998) Prevalence of nosocomial infections in representative German hospitals. J Hosp Infect 38(1): 37-49.
2. Andrade SS, Sader HS, Jones RN, Pereira AS, Pignatari ACC, Gales AC (2006) Increased resistance to first-line agents among bacterial pathogens isolated from urinary tract infections in Latin America: time for local guidelines? Memórias do Instituto Oswaldo Cruz 101(7): 741-748.
3. Fluit AC, Jones ME, Schmitz FJ, Acar J, Gupta R, Verhoef J (1997) (2000) Antimicrobial resistance among urinary tract infection (UTI) isolates in Europe: results from the SENTRY Antimicrobial Surveillance Program. Antonie van Leeuwenhoek 77(2): 147-152.
4. Wagenlehner FME, Niemetz A, Dalhoff A, Naber KG (2002) Spectrum and antibiotic resistance of uropathogens from hospitalized patients with urinary tract infections: 1994-2000. Int J Antimicrob Agents 19(6): 557-564.
5. Bjerklund Johansen TE, Cek M, Naber K, Stratchounski L, Svendsen MV, Tenke P (2007) Prevalence of hospital-acquired urinary tract infections in urology departments. Eur Urol 51(4): 1100-1112.
6. Johansen TE, Cek M, Naber KG, Stratchounski L, Svendsen MV, Tenke P (2006) Hospital acquired urinary tract infections in urology departments: pathogens, susceptibility and use of antibiotics. Data from the PEP and PEAP-studies. Int J Antimicrob Agents 28(Suppl 1): S91-S107.
7. Horan TC, Andrus M, Dudeck MA (2008) CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 36(5): 309-332.
8. Shaifali I, Gupta U, Mahmood SE, Ahmed J (2012) Antibiotic susceptibility patterns of urinary pathogens in female outpatients. N Am J Med Sci 4(4): 163-169.
9. Elhanan G, Sarhat M, Raz R (1997) Empiric antibiotic treatment and the misuse of culture results and antibiotic sensitivities in patients with community-acquired bacteraemia due to urinary tract infection. J infect 35(3): 283-288.
10. Cullen IM, Manecksha RP, McCullagh E, Ahmad S, O'Kelly F, Flynn RJ et al (2012) The changing pattern of antimicrobial resistance within 42, 033 Escherichia coli isolates from nosocomial, community and urology patient-specific urinary tract infections, Dublin, 1999-2009. BJU int 109(8): 1198-1206.
11. Kahlmeter G, Poulsen HOn (2012) Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO·SENS study revisited. Int J Antimicrob Agents 39(1): 45-51.
12. Bonkat G, Mller G, Braissant O, Frei R, Tschudin-Suter S, Rieken M, et al (2013) Increasing prevalence of ciprofloxacin resistance in extended-spectrum-ß-lactamase-producing Escherichia coli urinary isolates. World journal of urology.
13. Nys S, Terporten PH, Hoogkamp-Korstanje JAA, Stobberingh EE, Group SSS (2008) Trends in antimicrobial susceptibility of Escherichia coli isolates from urology services in The Netherlands (1998-2005). J antimicrobial chemotherapy 62(1): 126-132.
14. Peña C, Pujol M, Ricart A, Ardanuy C, Ayats J, Liñares J et al (1997) Risk factors for faecal carriage of Klebsiella pneumoniae producing extended spectrum beta-lactamase (ESBL-KP) in the intensive care unit. J Hosp Infect 35(1): 9-16.
15. Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO (2001) Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis 32(8): 1162-1171.
16. Akduman B, Akduman D, Tokgöz H, Erol B, Türker T, Ayoǧlu F et al (2011) Long-term fluoroquinolone use before the prostate biopsy may increase the risk of sepsis caused by resistant microorganisms. Urology 78(2): 250-255.
17. Cek M, Tandoǧdu Z, Naber K, Tenke P, Wagenlehner F, van Oostrum E, et al (2012) Antibiotic Prophylaxis in Urology Departments, 2005-2010. Eur Urol 63(2): 386-394.